Efficacy of the Hypomethylating Agents as Frontline, Salvage or Consolidation Therapy in Adults with Acute Myeloid Leukemia (AML)

BACKGROUND: The hypomethylating agents (HA), azacitidine and decitabine, have emerged as an alternative to initial and salvage therapy in patients with AML. Little is known about how AML responds to hypomethylating agents after standard therapy and the activity of these agents in a real world settin...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Tawfik, Bernard, Sliesoraitis, Sarunas, Lyerly, Susan, Klepin, Heidi D., Lawrence, Julia, Isom, Scott, Ellis, Leslie R., Manuel, Megan, Dralle, Sarah, Berenzon, Dmitriy, Powell, Bayard L., Pardee, Timothy
Formato: Artigo
Idioma:Inglês
Publicado em: 2013
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3879720/
https://ncbi.nlm.nih.gov/pubmed/24149914
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s00277-013-1940-9
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados